SPONSOR

Massachusetts General Hospital

Total Trials

Recruiting

Phases

Phase 1, Phase 2, EARLY_Phase 1, Phase 4

Conditions studied: Celiac Disease Depression Disorders Depression - Major Depressive Disorder Depression Disorder Depression Chronic Depression Depression in Adults Language Epilepsy Healthy

Massachusetts General Hospital is a clinical research sponsor with 47 registered studies on ClinicalTrials.gov, of which 47 are actively recruiting participants. Research covers conditions including Celiac Disease, Depression Disorders, Depression - Major Depressive Disorder, Depression Disorder.

The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Massachusetts General Hospital

How many clinical trials has Massachusetts General Hospital sponsored?

ClinicalMetric currently tracks 47 clinical trials sponsored by Massachusetts General Hospital, of which 47 are actively recruiting participants. These trials cover conditions including Celiac Disease, Depression Disorders, Depression - Major Depressive Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Massachusetts General Hospital research focus on?

Massachusetts General Hospital clinical trials span Celiac Disease, Depression Disorders, Depression - Major Depressive Disorder, Depression Disorder, Depression Chronic, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Massachusetts General Hospital clinical trial?

To participate in a Massachusetts General Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Massachusetts General Hospital trials with current recruitment status updated daily.

Massachusetts General Hospital

Frequently Asked Questions — Massachusetts General Hospital

Clinical Trials by Massachusetts General Hospital

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

Computational Neuroscience of Language Processing in the Human Brain

Physiology of Human Brain Connectivity

A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers

PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

ALS/MND Natural History Study Data Repository

Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

Cannabis, Linked Emotions, and Adolescent Risk Study

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

A Global Study of the PETAL Consortium

Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa

Omalizumab Weight-Based Dosing Efficacy Trial

Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

iNO300 Therapy in Critically Ill Patients With Pneumonia

Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

Just-in-time Interventions for Reducing Short-term Suicide Risk

Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONline

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

Time Restricted Eating (TRE) in Bipolar Disorder

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

Adaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in Zimbabwe

Developing Viability Index for Machine Perfused Livers

Outpatient Epcoritamab as 2L in NTE R/R DLBCL

Substrates for Post-Stroke Arm Rehabilitation

Impact of Cognitive Behavioral Therapy on PTSD-CVD Link

Building Connections

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap

Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults

Training in Evidence-based Treatments in Psycho-Oncology

Prostate Cancer Genetic Risk Evaluation and Screening Study

Mindfulness-based Cognitive Therapy vs the Health Enhancement Program for Chronic Pain and Depression; The Quiet Focus Study

A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

ELISA in Relapsed/Refractory MM

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Ziftomenib Maintenance Post Allo-HCT

Molecular and Genetic Analysis of Lung Cancer

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1